12:00 AM
Feb 02, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Fareston toremifene citrate regulatory update

EMEA's CHMP recommended that Orion's Fareston toremifene should not be used in patients at risk of...

Read the full 60 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >